Extramedullary Manifestation in Multiple Myeloma Bears High Incidence of Poor Cytogenetic Aberration and Novel Agents Resistance

Figure 3

The overall survival (OS) of patients with extramedullary disease at diagnosis and at relapse phase. The OS of patients with extramedullary involvement at initial diagnosis and patients experiencing extramedullary disease at relapse phase was 40 months and 27 months, respectively. No difference was shown in the OS between the two groups ().